Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.99 USD
17.78 M USD
65.30 M USD
6.58 M
About MEI Pharma, Inc.
Sector
CEO
Justin J. File
Headquarters
San Diego
Website
Founded
2000
FIGI
BBG000BSGT68
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MEIP is 2.60 USD — it has decreased by −4.44% in the past 24 hours. Watch MEI Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MEI Pharma, Inc. stocks are traded under the ticker MEIP.
MEIP stock has fallen by −4.80% compared to the previous week, the month change is a −13.42% fall, over the last year MEI Pharma, Inc. has showed a −59.50% decrease.
MEIP reached its all-time high on Feb 12, 2004 with the price of 15,720.00 USD, and its all-time low was 2.61 USD and was reached on Oct 9, 2024. View more price dynamics on MEIP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEIP stock is 3.59% volatile and has beta coefficient of −0.31. Track MEI Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is MEI Pharma, Inc. there?
Yes, you can track MEI Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
MEI Pharma, Inc. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
MEIP earnings for the last quarter are −1.20 USD per share, whereas the estimation was −1.70 USD resulting in a 29.41% surprise. The estimated earnings for the next quarter are −2.20 USD per share. See more details about MEI Pharma, Inc. earnings.
MEIP net income for the last quarter is −8.01 M USD, while the quarter before that showed −18.41 M USD of net income which accounts for 56.50% change. Track more MEI Pharma, Inc. financial stats to get the full picture.
As of Dec 18, 2024, the company has 28.00 employees. See our rating of the largest employees — is MEI Pharma, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEI Pharma, Inc. EBITDA is −37.53 M USD, and current EBITDA margin is 39.55%. See more stats in MEI Pharma, Inc. financial statements.
Like other stocks, MEIP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEI Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEI Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEI Pharma, Inc. stock shows the sell signal. See more of MEI Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.